Leading international law firm Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and underwriters of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (02315.HK)’s listing on the Main Board of the Hong Kong Stock Exchange.
Biocytogen listed on 1 September 2022. The company focuses on biopharmaceutical research and development, pre-clinical research services and antibody development.
“We are delighted to have worked with Biocytogen, one of the leading biopharmaceutical specialists, on its successful listing on the Hong Kong Stock Exchange,” said Hong Kong partner Matt Emsley. “We congratulate the company and the joint sponsors on this successful IPO.”
Herbert Smith Freehills has advised on a number of biotech listings since the Hong Kong Stock Exchange introduced its new regime for biotech listings in 2018, including those of Rainmed Medical Limited (02297.HK), Lepu Biopharma (02157.HK), Shanghai Bio-heart (02185.HK), Abbisko Cayman Limited (02256.HK), Acotec Scientific Holdings Limited (06669.HK), Shanghai HeartCare Medical Technology (06609.HK), Brii Biosciences (02137.HK), CARsgen Therapeutics (02171.HK), Antengene Corporation Limited (06996.HK), Peijia Medical (09996.HK), SinoMab BioScience Limited (03681.HK), TOT BIOPHARM (01875.HK) and Shanghai Junshi Biosciences (01877.HK).
“We have a proven record of advising Chinese companies seeking listings overseas, and we look forward to continuing to support issuers and sponsors on their fundraising activities,” said Herbert Smith Freehills Kewei join operation partner Stanley Xie.
“Our capital markets offering captures client needs in multiple sectors and jurisdictions,” said Hong Kong senior registered foreign lawyer Jin Kong. “In past three years, we have advised over 20 Chinese companies from healthcare, TMT and manufacturing sectors to list in Hong Kong and beyond.”
Partners Matt, Stanley and Jin jointly led the team advising the joint sponsors, assisted by senior associate Jaime Fong, associates Cyrus Wong, Kristina Li, Sean Ji, Haiyun Chen and Ting Wang and legal assistant Han Ye. Registered foreign lawyer Ariel Lin, legal manager Hilary Chong, trainee solicitor Colbert Hung, and legal assistants Jessica Lu and Tiffany Chan also provided support.
Legal manager Marine Jin led Herbert Smith Freehills Kewei Joint Operation’s Alternative Legal Services business to provide high-efficiency solutions for verification and other document-intensive processes during the listing, assisted by senior legal analyst Jean Zhou.
